S. Oelofse

发表

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Nguyen H. Tran, Vidyashankara G. Iyer, Andreas C. Themistocleous, 2020, Lancet.

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

Alimuddin Zumla, K. Dheda, A. Spanevello, 2017, European Respiratory Journal.

An Optimal Diagnostic Strategy for Tuberculosis in Hospitalized HIV-Infected Patients Using GeneXpert MTB/RIF and Alere Determine TB LAM Ag

K. Dheda, A. Pooran, M. Brar, 2020, Journal of Clinical Microbiology.

Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa

K. Dheda, R. Warren, A. Esmail, 2018, European Respiratory Journal.

Alone But Supported: A Qualitative Study of an HIV Self-testing App in an Observational Cohort Study in South Africa

N. Engel, A. Krumeich, K. Dheda, 2019, AIDS and Behavior.

A breath of relief: High-flow nasal oxygen in a resource-limited setting

K. Dheda, S. Oelofse, L. Kühn, 2022, African journal of thoracic and critical care medicine.

Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts

A. Diacon, K. Dheda, A. del Parigi, 2021, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Impact of a personalised, digital, HIV self-testing app-based program on linkages and new infections in the township populations of South Africa

N. Engel, K. Dheda, N. Pai, 2021, BMJ Global Health.

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Nguyen H. Tran, Vidyashankara G. Iyer, Andreas C. Themistocleous, 2021, The Lancet.

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

S. Madhi, A. Sigal, T. de Oliveira, 2021, The New England Journal of Medicine.

Outcomes of patients undergoing lung resection for drug-resistant TB and the prognostic significance of pre-operative positron emission tomography/computed tomography (PET/CT) in predicting treatment failure

K. Dheda, R. Steyn, T. Pennel, 2022, EClinicalMedicine.

Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b–2a trial

S. Madhi, S. Richardson, P. Moore, 2022, The Lancet Infectious Diseases.

An autologous dendritic cell vaccine polarizes a Th-1 response which is tumoricidal to patient-derived breast cancer cells

K. Dheda, R. Meldau, A. Pooran, 2018, Cancer Immunology, Immunotherapy.

Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa

S. Madhi, A. Sigal, T. de Oliveira, 2021, medRxiv.

Efficacy of the AZD1222 (ChAdOx1 nCoV-19) COVID-19 Vaccine Against SARS-CoV-2 Variants of Concern

J. Bhiman, K. Dheda, S. Barnabas, 2022, medRxiv.

SARS-CoV-2 viral replication persists in the human lung for several weeks after onset of symptomatic severe COVID-19 and is associated with attenuated pulmonary immunity and variant-specific clinical sequalae

S. Madhi, A. Sigal, C. Williamson, 2023, medRxiv.

Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)

S. Madhi, J. Bhiman, K. Dheda, 2023, Vaccine.

An All-Oral 6-Month Regimen for Multidrug-Resistant TB (the NExT Study): A Multicenter, Randomized Controlled Trial.

G. Maartens, K. Dheda, A. Pooran, 2022, American journal of respiratory and critical care medicine.

Comparison of two diagnostic intervention packages for community-based active case finding for tuberculosis: an open-label randomized controlled trial

K. Dheda, R. Meldau, A. Pooran, 2023, Nature Medicine.

ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine efficacy against the B.1.351 variant

S. Madhi, A. Sigal, T. de Oliveira, 2021, The New England Journal of Medicine.

SARS-CoV-2 Viral Replication Persists in the Human Lung for Several Weeks after Symptom Onset

S. Madhi, A. Sigal, K. Dheda, 2024, American journal of respiratory and critical care medicine.

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

S. Madhi, A. Sigal, P. Moore, 2021, The New England Journal of Medicine.